Journal of Medical Economics

Aims & Scope

Journal of Medical Economics is a MEDLINE-indexed, international journal publishing rigorously peer-reviewed review articles and original papers in the pharmacoeconomics and healthcare research community.

Journal of Medical Economics aims to help translate research advances into patient care and lead in transparency/disclosure.

The journal publishes high-quality economic assessments of novel therapeutic and device interventions for an international audience.

Journal of Medical Economics also specializes in the publication of studies that determine the effectiveness of medical treatment, involving measurements of therapeutic and/or preventative outcomes.

Methods employed in the studies commonly involve sets of patients with comparable clinical characteristics and include measurements of mortality, morbidity and patient-reported outcomes (including the patient’s quality of life, functional status and satisfaction with healthcare).

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3
2024	2.90

SJR (SCImago Journal Rank)

Year	Value
2024	0.927

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	58

Journal Rank

Year	Value
2024	5465

Journal Citation Indicator

Year	Value
2024	1232

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Hypoglycemia: An overview of fear of hypoglycemia, quality-of-life, and impact on costs

  Citation: 186

  Authors: Carrie, Torsten, Samantha

• The cost burden of multiple sclerosis in the United States: a systematic review of the literature

  Citation: 165

  Authors: Gabriel, Stanley G., Kathleen F.

• Health outcomes and economic burden of hospitalized COVID-19 patients in the United States

  Citation: 164

  Authors: Manuela, Kimberly M., Jay, Jennifer L., Frederick J., Michael, Deepa, Birol, Anita H., Jennifer L., Sophia, Apostolos

• Burden of illness in idiopathic pulmonary fibrosis

  Citation: 163

  Authors: Harold R., Alex J., Stephan, D., Daniel M., Elke

• Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder

  Citation: 155

  Authors: Mallik, Tingjian, Eunice, Ann, Maëlys, Michael S.

• Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation

  Citation: 148

  Authors: A. M., R., S., P.

• Comparative financing analysis and political economy of noncommunicable diseases

  Citation: 148

  Authors: Mihajlo, Melitta, Ulf, David, Seiritsu, Elena, Joav, Roza, Albert, Thomas E.

• Burden of venous leg ulcers in the United States

  Citation: 147

  Authors: J. Bradford, Urvi, Alice Kate G., Howard G., Michelle, Nathan

• Costs of managing severe hypoglycaemia in three European countries

  Citation: 134

  Authors: Mette, Morten, Susana Monereo, Werner, Brian M.

• The direct and indirect costs of long bone fractures in a working age US population

  Citation: 126

  Authors: Machaon, Derek, Anthony G.

---